Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Termination of refractory focal status epilepticus by the P-glycoprotein inhibitor verapamil.

Pirker S, Baumgartner C.

Eur J Neurol. 2011 Dec;18(12):e151. doi: 10.1111/j.1468-1331.2011.03513.x. No abstract available.

PMID:
22097953
2.

Use of verapamil as a potential P-glycoprotein inhibitor in a patient with refractory epilepsy.

Summers MA, Moore JL, McAuley JW.

Ann Pharmacother. 2004 Oct;38(10):1631-4. Epub 2004 Aug 24.

PMID:
15328394
3.
4.

Ketamine successfully terminates malignant status epilepticus.

Prüss H, Holtkamp M.

Epilepsy Res. 2008 Dec;82(2-3):219-22. doi: 10.1016/j.eplepsyres.2008.08.005. Epub 2008 Sep 19.

PMID:
18804344
5.

Comment: lacosamide for the treatment of refractory status epilepticus.

Trinka E, Höfler J, Tilz C, Kellinghaus C.

Ann Pharmacother. 2012 May;46(5):765-6; authors reply 766-7. doi: 10.1345/aph.1Q461a. Epub 2012 May 8. No abstract available.

PMID:
22570435
6.

Resective surgery to treat refractory status epilepticus in children with focal epileptogenesis.

Alexopoulos A, Lachhwani DK, Gupta A, Kotagal P, Harrison AM, Bingaman W, Wyllie E.

Neurology. 2005 Feb 8;64(3):567-70. Review.

PMID:
15699401
7.

Pentobarbital treatment of refractory status epilepticus.

Rashkin MC, Youngs C, Penovich P.

Neurology. 1987 Mar;37(3):500-3.

PMID:
3822147
8.

Teaching NeuroImage: Simple partial frontal status epilepticus with recurrent asymmetric tonic seizures.

Fernández-Torre JL, Leno C.

Neurology. 2008 Feb 12;70(7):e30-1. doi: 10.1212/01.wnl.0000297517.30566.5c. No abstract available.

PMID:
18268240
9.

Add-on treatment with verapamil in pharmacoresistant canine epilepsy.

Jambroszyk M, Tipold A, Potschka H.

Epilepsia. 2011 Feb;52(2):284-91. doi: 10.1111/j.1528-1167.2010.02886.x. Epub 2011 Jan 10.

10.

Refractory status epilepticus.

Bleck TP.

Curr Opin Crit Care. 2005 Apr;11(2):117-20. Review.

PMID:
15758590
11.

The use of levetiracetam in refractory status epilepticus.

Patel NC, Landan IR, Levin J, Szaflarski J, Wilner AN.

Seizure. 2006 Apr;15(3):137-41. Epub 2006 Jan 19.

12.

[Drug resistant status epilepticus].

Assal F, Coeytaux A, Jallon P.

Neurophysiol Clin. 2000 Jun;30(3):139-45. Review. French.

PMID:
10916820
13.

Intravenous levetiracetam in the treatment of benzodiazepine refractory status epilepticus.

Knake S, Gruener J, Hattemer K, Klein KM, Bauer S, Oertel WH, Hamer HM, Rosenow F.

J Neurol Neurosurg Psychiatry. 2008 May;79(5):588-9. Epub 2007 Sep 26.

PMID:
17898030
14.

The management of status epilepticus.

Shorvon S.

J Neurol Neurosurg Psychiatry. 2001 Jun;70 Suppl 2:II22-7. No abstract available.

15.

The use of lacosamide in refractory status epilepticus.

Goodwin H, Hinson HE, Shermock KM, Karanjia N, Lewin JJ 3rd.

Neurocrit Care. 2011 Jun;14(3):348-53. doi: 10.1007/s12028-010-9501-8.

PMID:
21249530
16.

Oral pregabalin as an add-on treatment for status epilepticus.

Novy J, Rossetti AO.

Epilepsia. 2010 Oct;51(10):2207-10. doi: 10.1111/j.1528-1167.2010.02646.x.

17.

Verapamil attenuates the malignant treatment course in recurrent status epilepticus.

Schmitt FC, Dehnicke C, Merschhemke M, Meencke HJ.

Epilepsy Behav. 2010 Apr;17(4):565-8. doi: 10.1016/j.yebeh.2010.01.166. Epub 2010 Mar 1.

PMID:
20189886
18.

Intravenous valproate in pediatric epilepsy patients with refractory status epilepticus.

Uberall MA, Trollmann R, Wunsiedler U, Wenzel D.

Neurology. 2000 Jun 13;54(11):2188-9. No abstract available.

PMID:
10851397
19.

Status epilepticus in central nervous system infections: an experience from a developing country.

Misra UK, Kalita J, Nair PP.

Am J Med. 2008 Jul;121(7):618-23. doi: 10.1016/j.amjmed.2008.02.012.

PMID:
18589058
20.

Refractory status epilepticus: frequency, risk factors, and impact on outcome.

Mayer SA, Claassen J, Lokin J, Mendelsohn F, Dennis LJ, Fitzsimmons BF.

Arch Neurol. 2002 Feb;59(2):205-10.

PMID:
11843690
Items per page

Supplemental Content

Write to the Help Desk